Clinical Trials

Showing trials with last updates posted in 2026.

NCT07191717 | RECRUITING | PHASE2
42 participants

Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2026-05-18
Completion:
2030-04-30
Conditions
  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Invasive Breast Carcinoma
  • Localized Estrogen Receptor-Positive Breast Carcinoma
  • Localized Human Epidermal Growth Factor Receptor (HER2)-Negative Breast Carcinoma
Interventions
  • DRUG
  • PROCEDURE
  • OTHER
No Results Yet
NCT07108335 | NOT_YET_RECRUITING | NA
404 participants

Provider and Patient RCT PROMOTE

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2026-10-01
Completion:
2028-08-31
Conditions
  • Maternal Health
  • Pregnancy
  • Employment
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page